Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10 - 29; http://dx.doi.org/10.3322/caac.20138; PMID: 22237781
   PubMed Web of Science ®Google Scholar
• Yuan Y, Liao YM, Hsueh CT, Mirshahidi HR. Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP. J Hematol Oncol 2011; 4:16; http://dx.doi.org/10.1186/1756-8722-4-16; PMID: 21504625
   PubMed Web of Science ®Google Scholar
• Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY, Hu HZ, et al. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs. Int J Mol Med 2011; 28:769 - 76; PMID: 21837360
   PubMed Web of Science ®Google Scholar
• Mackinnon AC, Tretiakova M, Henderson L, Mehta RG, Yan BC, Joseph L, et al. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. J Clin Pathol 2011; 64:16 - 24; http://dx.doi.org/10.1136/jcp.2010.075853; PMID: 21045234
   PubMed Web of Science ®Google Scholar
• Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY, et al. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res 2008; 68:132 - 42; http://dx.doi.org/10.1158/0008-5472.CAN-07-1998; PMID: 18172305
   PubMed Web of Science ®Google Scholar
• Sattler M, Pisick E, Morrison PT, Salgia R. Role of the cytoskeletal protein paxillin in oncogenesis. Crit Rev Oncog 2000; 11:63 - 76; http://dx.doi.org/10.1615/CritRevOncog.v11.i1.30; PMID: 10795627
   PubMed Web of Science ®Google Scholar
• Turner CE. Paxillin interactions. J Cell Sci 2000; 113:4139 - 40; PMID: 11069756
   PubMed Web of Science ®Google Scholar
• Vande Pol SB, Brown MC, Turner CE. Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 1998; 16:43 - 52; http://dx.doi.org/10.1038/sj.onc.1201504; PMID: 9467941
   PubMed Web of Science ®Google Scholar
• Turner CE, Glenney JR Jr., Burridge K. Paxillin: a new vinculin-binding protein present in focal adhesions. J Cell Biol 1990; 111:1059 - 68; http://dx.doi.org/10.1083/jcb.111.3.1059; PMID: 2118142
   PubMed Web of Science ®Google Scholar
• Deakin NO, Turner CE. Paxillin comes of age. J Cell Sci 2008; 121:2435 - 44; http://dx.doi.org/10.1242/jcs.018044; PMID: 18650496
   PubMed Web of Science ®Google Scholar
• Lawson C, Schlaepfer DD. Integrin adhesions: who’s on first? What’s on second? Connections between FAK and talin. Cell Adh Migr 2012; 6:302 - 6; http://dx.doi.org/10.4161/cam.20488; PMID: 22983197
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004; 4:891 - 9; http://dx.doi.org/10.1038/nrc1478; PMID: 15516961
   PubMed Web of Science ®Google Scholar
• Rehman J, Zhang HJ, Toth PT, Zhang Y, Marsboom G, Hong Z, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J 2012; 26:2175 - 86; http://dx.doi.org/10.1096/fj.11-196543; PMID: 22321727
   PubMed Web of Science ®Google Scholar
• Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 2002; 13:41 - 59; http://dx.doi.org/10.1016/S1359-6101(01)00029-6; PMID: 11750879
   PubMed Web of Science ®Google Scholar
• Ma PC, Jagadeeswaran R, Jagadeesh S, Tretiakova MS, Nallasura V, Fox EA, et al. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res 2005; 65:1479 - 88; http://dx.doi.org/10.1158/0008-5472.CAN-04-2650; PMID: 15735036
   PubMed Web of Science ®Google Scholar
• Knott AB, Bossy-Wetzel E. Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration. Ann N Y Acad Sci 2008; 1147:283 - 92; http://dx.doi.org/10.1196/annals.1427.030; PMID: 19076450
   PubMed Web of Science ®Google Scholar
• Zhu J, Yang Y, Wu J. Bcl-2 cleavages at two adjacent sites by different caspases promote cisplatin-induced apoptosis. Cell Res 2007; 17:441 - 8; PMID: 17452997
   PubMed Web of Science ®Google Scholar
• Stathopoulos GP, Boulikas T. Lipoplatin formulation review article. J Drug Deliv 2012; 2012:581363; http://dx.doi.org/10.1155/2012/581363; PMID: 21904682
   PubMedGoogle Scholar
• Warburg O. On Metabolism of tumors. (Constable, London; 1930).
   Google Scholar
• Plathow C, Weber WA. Tumor cell metabolism imaging. J Nucl Med 2008; 49:Suppl 2 43S - 63S; http://dx.doi.org/10.2967/jnumed.107.045930; PMID: 18523065
   PubMed Web of Science ®Google Scholar
• Plas DR, Thompson CB. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 2002; 13:75 - 8; http://dx.doi.org/10.1016/S1043-2760(01)00528-8; PMID: 11854022
   PubMedGoogle Scholar
• Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic beta-cells. Nature 2001; 414:807 - 12; http://dx.doi.org/10.1038/414807a; PMID: 11742413
   PubMed Web of Science ®Google Scholar
• Cannino G, Di Liegro CM, Rinaldi AM. Nuclear-mitochondrial interaction. Mitochondrion 2007; 7:359 - 66; http://dx.doi.org/10.1016/j.mito.2007.07.001; PMID: 17822963
   PubMed Web of Science ®Google Scholar
• Brini M. Ca(2+) signalling in mitochondria: mechanism and role in physiology and pathology. Cell Calcium 2003; 34:399 - 405; http://dx.doi.org/10.1016/S0143-4160(03)00145-3; PMID: 12909084
   PubMed Web of Science ®Google Scholar
• Gunter TE, Buntinas L, Sparagna G, Eliseev R, Gunter K. Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 2000; 28:285 - 96; http://dx.doi.org/10.1054/ceca.2000.0168; PMID: 11115368
   PubMed Web of Science ®Google Scholar
• Gunter TE, Yule DI, Gunter KK, Eliseev RA, Salter JD. Calcium and mitochondria. FEBS Lett 2004; 567:96 - 102; http://dx.doi.org/10.1016/j.febslet.2004.03.071; PMID: 15165900
   PubMed Web of Science ®Google Scholar
• Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003; 160:189 - 200; http://dx.doi.org/10.1083/jcb.200211046; PMID: 12527753
   PubMed Web of Science ®Google Scholar
• Tondera D, Grandemange S, Jourdain A, Karbowski M, Mattenberger Y, Herzig S, et al. SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J 2009; 28:1589 - 600; http://dx.doi.org/10.1038/emboj.2009.89; PMID: 19360003
   PubMed Web of Science ®Google Scholar
• Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ. Role of Bax and Bak in mitochondrial morphogenesis. Nature 2006; 443:658 - 62; http://dx.doi.org/10.1038/nature05111; PMID: 17035996
   PubMed Web of Science ®Google Scholar
• Karbowski M, Arnoult D, Chen H, Chan DC, Smith CL, Youle RJ. Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol 2004; 164:493 - 9; http://dx.doi.org/10.1083/jcb.200309082; PMID: 14769861
   PubMed Web of Science ®Google Scholar
• Skulachev VP, Bakeeva LE, Chernyak BV, Domnina LV, Minin AA, Pletjushkina OY, et al. Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis. Mol Cell Biochem 2004; 256-257:341 - 58; http://dx.doi.org/10.1023/B:MCBI.0000009880.94044.49; PMID: 14977193
   PubMed Web of Science ®Google Scholar
• Wallace DC, Brown MD, Lott MT. Mitochondrial DNA variation in human evolution and disease. Gene 1999; 238:211 - 30; http://dx.doi.org/10.1016/S0378-1119(99)00295-4; PMID: 10570998
   PubMed Web of Science ®Google Scholar
• Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39:359 - 407; http://dx.doi.org/10.1146/annurev.genet.39.110304.095751; PMID: 16285865
   PubMed Web of Science ®Google Scholar
• Delivani P, Adrain C, Taylor RC, Duriez PJ, Martin SJ. Role for CED-9 and Egl-1 as regulators of mitochondrial fission and fusion dynamics. Mol Cell 2006; 21:761 - 73; http://dx.doi.org/10.1016/j.molcel.2006.01.034; PMID: 16543146
   PubMed Web of Science ®Google Scholar
• Salgia R, Li JL, Lo SH, Brunkhorst B, Kansas GS, Sobhany ES, et al. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem 1995; 270:5039 - 47; http://dx.doi.org/10.1074/jbc.270.10.5039; PMID: 7534286
   PubMed Web of Science ®Google Scholar
• Grandemange S, Herzig S, Martinou JC. Mitochondrial dynamics and cancer. Semin Cancer Biol 2009; 19:50 - 6; http://dx.doi.org/10.1016/j.semcancer.2008.12.001; PMID: 19138741
   PubMed Web of Science ®Google Scholar
• Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol 2000; 2:E231 - 6; http://dx.doi.org/10.1038/35046659; PMID: 11146675
   PubMed Web of Science ®Google Scholar
• Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL. Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 1987; 55:513 - 6; http://dx.doi.org/10.1038/bjc.1987.104; PMID: 3038157
   PubMed Web of Science ®Google Scholar
• Santin G, Piccolini VM, Barni S, Veneroni P, Giansanti V, Dal Bo V, et al. Mitochondrial fusion: a mechanism of cisplatin-induced resistance in neuroblastoma cells?. Neurotoxicology 2013; 34:51 - 60; http://dx.doi.org/10.1016/j.neuro.2012.10.011; PMID: 23103224
   PubMed Web of Science ®Google Scholar